Message Font: Serif | Sans-Serif
No. of Recommendations: 1
I am sure the details are in the 10ks etc but its a common option in biotech. EXEL has the right, at its own expense, to get a greater share of the profit as long as it contributes to the expense of marketing as well. Something to that effect. If it chooses not to exercise the option, then expense will be Genetech's expense and EXEL will get a smaller royalty on the sale of the drug.

So EXEL has a time frame to determine if they want to invest cash in marketing (and sometimes in development, there may be other costs or a price for EXEL to pay to exercise this option) or just take the royalty and forget about it.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.